Repeat liver resection or transarterial chemoembolization (TACE) can be used for disease progression (PD) of hepatocellular carcinoma (HCC), but when patients developed extrahepatic metastasis or macrovascular invasion which was aggressive disease progression (aggressive-PD), the treatments became a challenge. Therefore, it was meaningful to predict aggressive-PD as early as possible considering the current prediction method in clinical was unreliable. In this study, a deep learning model was conducted to predict aggressive-PD. 333 patients receiving hepatectomy or TACE were enrolled from five hospitals. For each patient, deep learning score was calculated from a convolutional neural network model constructed based on resnet block. The model showed excellent performance for individualized, non-invasive prediction of the progression of Hepatocellular carcinoma (training set: ACC=75.61%, AUC=0.81, validation set: ACC=87.36%, AUC=0.82). Pearson correlation analysis showed albumin concentration were significantly correlated with deep learning score.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.